2022 Nucleic Acid Testing Market Competitive Landscape: Shares by Country and Strategic Assessments of Leading Suppliers
April 7, 2022
VPG Market Research
90
PDF
2022 Nucleic Acid Testing Market Competitive Landscape: Shares by Country and Strategic Assessments of Leading Suppliers
Abstract
This report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products.
This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Content Table of Contents The report provides strategic assessments of leading molecular diagnostics market players and start-up companies with innovative technologies and products, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher Becton Dickinson Biokit bioMerieux Bio-Rad Cellmark Forensics/LabCorp Decode Genetics Diadexus Diasorin Eiken Chemical Elitech Group Enzo Biochem Exact Sciences Fujirebio Grifols Hologic/Gen-Probe Illumina Leica Biosystems/Kreatech Li-Cor Biosciences Myriad Genetics Ortho-Clinical Diagnostics/Carlyle Group Proteome Sciences Qiagen Quest Diagnostics Quidel Roche Sequenom Shimadzu Siemens Healthineers Takara Bio Tecan Group Thermo Fisher
This report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products.
This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Table of Contents The report provides strategic assessments of leading molecular diagnostics market players and start-up companies with innovative technologies and products, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher Becton Dickinson Biokit bioMerieux Bio-Rad Cellmark Forensics/LabCorp Decode Genetics Diadexus Diasorin Eiken Chemical Elitech Group Enzo Biochem Exact Sciences Fujirebio Grifols Hologic/Gen-Probe Illumina Leica Biosystems/Kreatech Li-Cor Biosciences Myriad Genetics Ortho-Clinical Diagnostics/Carlyle Group Proteome Sciences Qiagen Quest Diagnostics Quidel Roche Sequenom Shimadzu Siemens Healthineers Takara Bio Tecan Group Thermo Fisher